Pregabalin: a new anxiolytic

Author： Lauria-Horner Bianca A Pohl Robert B

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.4, 2003-04, pp. : 663-672

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pregabalin treatment of choice in new diabetic pain guideline

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 627, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Analysis and standardization of the new anxiolytic drug afobazole

By Milkina S. Stepanenko O. Grushevskaya L. Avdyunina N. Pyatin B. Bagirova V. Nechaeva E.

Pharmaceutical Chemistry Journal, Vol. 40, Iss. 7, 2006-07 ,pp. : 405-406

Springer Publishing Company

Access to resources Recommend Favorite

Pregabalin: Rash: case report

Reactions Weekly, Vol. 1, Iss. 1229, 2008-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite

Pregabalin: In the Treatment of Postherpetic Neuralgia

By McKeage Kate Keam Susan J.

Drugs & Aging, Vol. 26, Iss. 10, 2009-10 ,pp. : 883-892

Adis International

Access to resources Recommend Favorite

Pregabalin: Delirium: case report

Reactions Weekly, Vol. 1, Iss. 1417, 2012-01 ,pp. : 37-37

Adis International

Access to resources Recommend Favorite